{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,30]],"date-time":"2026-03-30T15:39:30Z","timestamp":1774885170546,"version":"3.50.1"},"reference-count":38,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"8","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2004,8]]},"DOI":"10.1097\/01.hjh.0000133733.32125.09","type":"journal-article","created":{"date-parts":[[2004,7,15]],"date-time":"2004-07-15T08:07:41Z","timestamp":1089878861000},"page":"1613-1622","source":"Crossref","is-referenced-by-count":122,"title":["Equivalence of indapamide SR and enalapril on microalbuminuria reduction in hypertensive patients with type 2 diabetes"],"prefix":"10.1097","volume":"22","author":[{"given":"Michel","family":"Marre","sequence":"first","affiliation":[]},{"given":"Juan Garcia","family":"Puig","sequence":"additional","affiliation":[]},{"given":"Franciszek","family":"Kokot","sequence":"additional","affiliation":[]},{"given":"Margarita","family":"Fernandez","sequence":"additional","affiliation":[]},{"given":"Gy\u00f6rgy","family":"Jermendy","sequence":"additional","affiliation":[]},{"given":"Lionel","family":"Opie","sequence":"additional","affiliation":[]},{"given":"Valentin","family":"Moyseev","sequence":"additional","affiliation":[]},{"given":"Andr\u00e9","family":"Scheen","sequence":"additional","affiliation":[]},{"given":"Constantin","family":"Ionescu-Tirgoviste","sequence":"additional","affiliation":[]},{"given":"M Helena","family":"Saldanha","sequence":"additional","affiliation":[]},{"given":"Aaron","family":"Halabe","sequence":"additional","affiliation":[]},{"given":"Bryan","family":"Williams","sequence":"additional","affiliation":[]},{"given":"Decio","family":"Mion","sequence":"additional","affiliation":[]},{"given":"Maximino","family":"Ruiz","sequence":"additional","affiliation":[]},{"given":"Kjeld","family":"Hermansen","sequence":"additional","affiliation":[]},{"given":"Jaakko","family":"Tuomilehto","sequence":"additional","affiliation":[]},{"given":"Bartolom\u00e9","family":"Finizola","sequence":"additional","affiliation":[]},{"given":"Yves","family":"Gallois","sequence":"additional","affiliation":[]},{"given":"Philippe","family":"Amouyel","sequence":"additional","affiliation":[]},{"given":"Jean-Pierre","family":"Ollivier","sequence":"additional","affiliation":[]},{"given":"Roland","family":"Asmar","sequence":"additional","affiliation":[]}],"member":"276","reference":[{"key":"R1-28-20210208","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.1056\/NEJM200004063421408","article-title":"Coronary heart disease in patients with diabetes.","volume":"342","author":"Haffner","year":"2000","journal-title":"N Engl J Med"},{"key":"R2-28-20210208","doi-asserted-by":"crossref","first-page":"434","DOI":"10.2337\/diacare.16.2.434","article-title":"Diabetes, other risk factors, and 12-yr cardiovascular mortality for men screened in the Multiple Risk Factor Intervention Trial.","volume":"16","author":"Stamler","year":"1993","journal-title":"Diabetes Care"},{"key":"R4-28-20210208","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1056\/NEJM198402093100605","article-title":"Microalbuminuria predicts clinical proteinuria and early mortality in maturity-onset diabetes.","volume":"310","author":"Mogensen","year":"1984","journal-title":"N Engl J Med"},{"key":"R5-28-20210208","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1111\/j.1464-5491.1984.tb01973.x","article-title":"The Whitehall Study: ten year follow-up report on men with impaired glucose tolerance with reference to worsening diabetes and predictors of death.","volume":"1","author":"Jarrett","year":"1984","journal-title":"Diab Med"},{"key":"R6-28-20210208","doi-asserted-by":"crossref","first-page":"736","DOI":"10.2337\/diab.41.6.736","article-title":"Prospective study of microalbuminuria as predictor of mortality in NIDDM.","volume":"41","author":"Mattock","year":"1992","journal-title":"Diabetes"},{"key":"R7-28-20210208","first-page":"253","article-title":"Effects of ramipril on cardiovascular and microvascular outcomes in people with diabetes mellitus: results of the HOPE study and MICRO-HOPE substudy [published erratum appears in Lancet 2000; 356:860] L","volume":"355","year":"2000","journal-title":"ancet"},{"key":"R8-28-20210208","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1136\/bmj.297.6656.1092","article-title":"Prevention of diabetic nephropathy with enalapril in normotensive diabetics with microalbuminuria.","volume":"297","author":"Marre","year":"1988","journal-title":"BMJ"},{"key":"R9-28-20210208","doi-asserted-by":"crossref","first-page":"1456","DOI":"10.1056\/NEJM199311113292004","article-title":"The effect of angiotensin-converting-enzyme inhibition on diabetic nephropathy. The Collaborative Study Group [published erratum appears in N Engl J Med 1993; 330:152].","volume":"329","author":"Lewis","year":"1993","journal-title":"N Engl J Med"},{"key":"R10-28-20210208","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1056\/NEJMoa011303","article-title":"Collaborative Study Group. Renoprotective effect of the angiotensin-receptor antagonist irbesartan in patients with nephropathy due to type 2 diabetes.","volume":"345","author":"Lewis","year":"2001","journal-title":"N Engl J Med"},{"key":"R11-28-20210208","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1056\/NEJMoa011161","article-title":"RENAAL Study Investigators. Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy.","volume":"345","author":"Brenner","year":"2001","journal-title":"N Engl J Med"},{"key":"R12-28-20210208","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1136\/bmj.306.6871.175","article-title":"Comparison of reduction in microalbuminuria by enalapril and hydrochlorothiazide in normotensive patients with insulin dependent diabetes.","volume":"306","author":"Hallab","year":"1993","journal-title":"BMJ"},{"key":"R14-28-20210208","first-page":"145","article-title":"The Heart Outcomes Prevention Evaluation Study Investigators. Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients [published errata appear in N Engl J Med 2000; 342:748, 1376].","volume":"342","author":"Yusuf","year":"2000","journal-title":"N Engl J Med"},{"key":"R15-28-20210208","doi-asserted-by":"crossref","first-page":"E28","DOI":"10.1161\/hy1101.099502","article-title":"Comparative effects of ramipril on ambulatory and office blood pressures: a HOPE Substudy.","volume":"38","author":"Svensson","year":"2001","journal-title":"Hypertension"},{"key":"R16-28-20210208","doi-asserted-by":"crossref","first-page":"1190","DOI":"10.1016\/S0140-6736(74)91002-2","article-title":"Increased urinary albumin excretion rate in benign essential hypertension.","volume":"15","author":"Parving","year":"1974","journal-title":"Lancet"},{"key":"R17-28-20210208","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1007\/BF00400995","article-title":"Prevalence of micro and macroalbuminuria, arterial hypertension, retinopathy and large vessel disease in European type 2 (non-insulin-dependent) diabetic patients.","volume":"34","author":"Gall","year":"1991","journal-title":"Diabetologia"},{"issue":"suppl 1","key":"R18-28-20210208","doi-asserted-by":"crossref","first-page":"S19","DOI":"10.1097\/01.hjh.0000271505.69949.9d","article-title":"Effect of indapamide SR on microalbuminuria - The NESTOR study (Natrilix SR versus Enalapril Study in Type 2 diabetic hypertensives with micrOalbuminuRia). Rationale and protocol for the main trial.","volume":"21","author":"Marre","year":"2003","journal-title":"J Hypertens"},{"key":"R19-28-20210208","doi-asserted-by":"crossref","first-page":"639","DOI":"10.7326\/0003-4819-109-8-639","article-title":"Screening for diabetes mellitus.","volume":"109","author":"Singer","year":"1988","journal-title":"Ann Intern Med"},{"key":"R20-28-20210208","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1093\/clinchem\/33.2.209","article-title":"Laser immunonephlometry for routine quantification of urinary albumin excretion.","volume":"33","author":"Marre","year":"1987","journal-title":"Clin Chem"},{"key":"R21-28-20210208","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1159\/000180580","article-title":"Prediction of creatinine clearance from serum creatinine.","volume":"16","author":"Cockcroft","year":"1976","journal-title":"Nephron"},{"key":"R23-28-20210208","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1097\/00004872-199007000-00004","article-title":"The British Hypertension Society protocol for the evaluation of automated and semi-automated blood pressure measuring devices with special references to ambulatory systems.","volume":"8","author":"O'Brien","year":"1990","journal-title":"J Hypertens"},{"key":"R25-28-20210208","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1161\/01.HYP.21.4.504","article-title":"National standard for measurement of resting and ambulatory blood pressure with automated sphygmomanometers.","volume":"21","author":"White","year":"1993","journal-title":"Hypertension"},{"key":"R26-28-20210208","first-page":"1137","article-title":"Mesure ambulatoire non invasive de la pression arterielle. Recommandations du groupe de la mesure de la Societe francaise d'hypertension arterielle.","volume":"86","author":"Poggi","year":"1993","journal-title":"Arch Mal Coeur"},{"key":"R27-28-20210208","first-page":"1175","article-title":"Mesures ambulatoires de la pression arterielle et essais therapeutiques.","volume":"88","author":"Andrejak","year":"1995","journal-title":"Arch Mal Coeur"},{"key":"R28-28-20210208","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1016\/S0272-6386(12)80668-8","article-title":"Long-term treatment with either enalapril or nitrendipine stabilizes albuminuria and increases glomerular filtration rate in non-insulin- dependent diabetic patients.","volume":"24","author":"Ruggenenti","year":"1994","journal-title":"Am J Kidney Dis"},{"key":"R29-28-20210208","doi-asserted-by":"crossref","first-page":"1465","DOI":"10.1097\/00004872-200018100-00015","article-title":"Regression of left ventricular hypertrophy in hypertensive patients treated with indapamide SR 1.5 mg versus enalapril 20 mg: the LIVE study.","volume":"18","author":"Gosse","year":"2000","journal-title":"J Hypertens"},{"key":"R30-28-20210208","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1016\/0002-9149(87)91182-9","article-title":"Comparison of enalapril and bendrofluazide for treatment of systemic hypertension.","volume":"59","author":"Zezulka","year":"1987","journal-title":"Am J Cardiol"},{"issue":"suppl 4","key":"R31-28-20210208","doi-asserted-by":"crossref","first-page":"S464","DOI":"10.1097\/00004872-198812040-00146","article-title":"Angiotensin converting enzyme inhibition with a low dose of enalapril in normotensive diabetics with persistent proteinuria.","volume":"6","author":"Stornello","year":"1988","journal-title":"J Hypertens"},{"key":"R32-28-20210208","doi-asserted-by":"crossref","first-page":"346","DOI":"10.2165\/00003495-199243030-00005","article-title":"Enalapril: a preappraisal of its pharmacology and therapeutic use in hypertension.","volume":"43","author":"Todd","year":"1992","journal-title":"Drugs"},{"key":"R33-28-20210208","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1001\/archinte.1996.00440030080010","article-title":"Long term renoprotective effect of angiotensin-converting enzyme inhibition in non-insulin-diabetes mellitus. A 7-year follow-up study.","volume":"156","author":"Ravid","year":"1996","journal-title":"Arch Int Med"},{"key":"R34-28-20210208","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1136\/bmj.304.6823.339","article-title":"Renal protective effect of enalapril in diabetic nephropathy.","volume":"304","author":"Bjork","year":"1992","journal-title":"BMJ"},{"key":"R35-28-20210208","doi-asserted-by":"crossref","first-page":"1108","DOI":"10.2337\/diab.43.9.1108","article-title":"Impact of lisinopril and atenolol on kidney function in hypertensive NIDDM subjects with diabetic nephropathy.","volume":"43","author":"Nielsen","year":"1994","journal-title":"Diabetes"},{"key":"R36-28-20210208","doi-asserted-by":"crossref","first-page":"1182","DOI":"10.2337\/diab.46.7.1182","article-title":"Long-term effect of lisinopril and atenolol on kidney function in hypertensive NIDDM subjects with diabetic nephropathy.","volume":"46","author":"Nielsen","year":"1997","journal-title":"Diabetes"},{"key":"R37-28-20210208","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1136\/bmj.317.7160.713","article-title":"UKPDS 39. Efficacy of atenolol and captopril in reducing risk of macrovascular and microvascular complications in type 2 diabetes.","volume":"317","year":"1998","journal-title":"BMJ"},{"key":"R38-28-20210208","doi-asserted-by":"crossref","first-page":"1569","DOI":"10.1007\/s001250050616","article-title":"Patterns of renal injury in NIDDM patients with microalbuminuria.","volume":"39","author":"Fioretto","year":"1996","journal-title":"Diabetologia"},{"key":"R40-28-20210208","first-page":"2981","article-title":"Major outcomes in high risk hypertensive patients randomised to angiotensin converting enzyme inhibitor or calcium channel blocker vs diuretic. The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT).","volume":"228","year":"2002","journal-title":"JAMA"},{"key":"R41-28-20210208","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1016\/S0140-6736(98)07019-6","article-title":"Intensive blood-glucose with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes. (UKPDS 33).","volume":"352","year":"1998","journal-title":"Lancet"},{"key":"R43-28-20210208","doi-asserted-by":"crossref","first-page":"2560","DOI":"10.1001\/jama.289.19.2560","article-title":"The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. The JNC 7 Report.","volume":"289","year":"2003","journal-title":"JAMA"},{"key":"R44-28-20210208","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1097\/00004872-200306000-00001","article-title":"2003 European Society of Hypertension- European Society of Cardiology guidelines for the management of arterial hypertension.","volume":"21","year":"2003","journal-title":"J Hypertens"}],"container-title":["Journal of Hypertension"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/01.hjh.0000133733.32125.09","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,13]],"date-time":"2021-05-13T20:47:18Z","timestamp":1620938838000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00004872-200408000-00028"}},"subtitle":["The NESTOR* study"],"short-title":[],"issued":{"date-parts":[[2004,8]]},"references-count":38,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2004]]}},"URL":"https:\/\/doi.org\/10.1097\/01.hjh.0000133733.32125.09","relation":{},"ISSN":["0263-6352"],"issn-type":[{"value":"0263-6352","type":"print"}],"subject":[],"published":{"date-parts":[[2004,8]]}}}